Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT04488354

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

NCT01679119

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stoke Mandeville Hospital (including Wycombe Hospital) Aylesbury, United Kingdom
  • North Hampshire Hospital Basingstoke, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 40 locations
View Trial Details
Completed

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

NCT06492304

Conditions
Acute Myeloid Leukemia, B Cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Research Site 6 Phoenix, Arizona, United States
  • Research Site 5 Stanford, California, United States
  • Research Site 3 Boston, Massachusetts, United States
  • Research Site 4 New York, United States
View Trial Details
Completed

Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma

NCT00428142

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Controlling Hypertension Through Education and Coaching in Kidney Disease

NCT04087798

Conditions
Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease Stage 5, +26 more
Locations
  • University of Michigan / Domino's Farms Ann Arbor, Michigan, United States
  • University of Michigan / Briarwood Family Medicine Ann Arbor, Michigan, United States
  • University of Michigan / Brighton Health Center Brighton, Michigan, United States
  • University of Michigan / Canton Health Center Canton, Michigan, United States
View Trial Details
Completed

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

NCT01846390

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions